Remifentanil for INSURE in preterm infants: a pilot study for evaluation of efficacy and safety aspects
Authors:
- L WelzingLWL Welzing
- A KribsAKA Kribs
- C HuenselerCHC Huenseler
- F EifingerFEF Eifinger
- K MehlerKMK Mehler
- B RothBRB Roth
- 1 May 2009
- journal article
- research article
- Published by Wiley in Acta Paediatrica
- Vol. 98 (9) , 1416-20
Abstract
To evaluate intubating conditions, extubation times and outcome in preterm infants receiving remifentanil as induction agent for the INSURE procedure. In twenty-one preterm infants of 29 to 32 weeks gestation and signs of respiratory distress, we utilized remifentanil as induction agent for the INSURE procedure. Following intubation and surfactant application, the infants were mechanically ventilated until respiratory drive was judged to be satisfactory for continuing CPAP therapy. Intubating conditions were classified by our own scoring system by rating limb movements, coughing and breathing. Heart rate, blood pressure and oxygen saturation were recorded during the entire INSURE procedure. Remifentanil provided excellent or good intubating conditions in all patients. We observed no serious side effects after remifentanil infusion, in particular, no thorax rigidity, clinically significant bradycardia or arterial hypotension. Average extubation time after surfactant administration was 16.9 min (1-45 min); none of the infants had to be reintubated. Following extubation, the infants required only 3.3 days (1-8 days) of CPAP therapy. None exhibited serious complications of prematurity like periventricular leucomalacia, intraventricular haemorrhage >I degree, necrotizing enterocolitis or retinopathy. In this pilot study, INSURE with remifentanil was associated with good intubating conditions and early extubation resulting in an excellent neonatal outcome.Keywords
This publication has 29 references indexed in Scilit:
- A controlled comparison between single doses of intravenous and intramuscular morphine with respect to analgesic effects and patient safetyActa Anaesthesiologica Scandinavica, 2008
- Cardiac arrest following naloxone in an extremely preterm neonateEuropean Journal of Pediatrics, 2008
- A comparison of intubating conditions in children following induction of anaesthesia with propofol and suxamethonium or propofol and remifentanilAnaesthesia, 2006
- Delayed Extubation to Nasal Continuous Positive Airway Pressure in the Immature Baboon Model of Bronchopulmonary Dysplasia: Lung Clinical and Pathological FindingsPediatrics, 2006
- Morphine versus remifentanil for intubating preterm neonatesArchives of Disease in Childhood - Fetal and Neonatal Edition, 2006
- Experience with Remifentanil in Neonates and InfantsDrugs, 2006
- Dose-Response of Remifentanil for Tracheal Intubation in InfantsAnesthesia & Analgesia, 2005
- Assessment of tracheal intubating conditions in children using remifentanil and propofol without muscle relaxantPediatric Anesthesia, 2004
- A Multicenter Randomized, Placebo-Controlled Trial of Surfactant Therapy for Respiratory Distress SyndromeNew England Journal of Medicine, 1989
- A technique for delivery of continuous positive airway pressure to the neonateThe Journal of Pediatrics, 1976